Zenas BioPharmaGrove City, Ohio, United States
Clinical Pharmacology & Pharmacometrics
0536: A Population Modeling and Simulation of the Effect of Obexelimab Exposure on the QTc Interval in Healthy Volunteers and Patients with Rheumatoid Arthritis or IgG4-Related Disease
Saturday, November 16, 202410:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose